How Origami Risk CEO Bob Petrie grew Origami Risk to $59M revenue with a 2 person team in 2024.

Adlook

Adlook is a global media tech company specializing in guaranteed media performance and zero-ad waste solutions, focusing on privacy and technology in digital advertising.

Boom

Economically and environmentally sustainable supersonic travel

porter.in

Porter is a leading logistics service provider offering a wide range of goods transportation solutions. They operate as a provider of on-demand transportation solutions for goods and intercity courier services, aiming to streamline and optimize last-mile delivery operations.

U.S. Compliance

U.S. Compliance specializes in Regulatory Compliance Management and Consulting, providing OSHA compliance and environmental compliance solutions. The company has nearly 30 years of experience in environmental, health, and safety consulting.

Fay Nutrition

Fay helps users choose a dietitian, arranges virtual and in-person meetings, designs a custom plan for each client, and works with insurance to get it covered, enabling people to receive fully customized nutrition counseling at an affordable price.

ABL

With a 60+ year history as a service provider to the life sciences industry, Advanced BioScience Laboratories (ABL) provides a strong core of product development expertise, GMP manufacturing, and analytical testing capabilities. Founded in 1961 as a biomedical research contractor for the federal government, ABL has made major contributions to the development and evaluation of a wide range of life-saving diagnostics, vaccines, and therapeutics designed to combat the world’s most challenging diseases. We partner with our clients to support advancement of their candidate vaccines and therapeutics through preclinical and clinical development. With facilities located in the United States, ABL aims to be a seamless extension of our clients’ team – helping them advance today’s ideas into tomorrow’s medicines. ABL's CDMO service division specializes in the development and manufacturing of GMP cell banks and viral vectors from the bench to Phase I/II clinical trials. We aim to contributes to the success of our clients' ground-breaking innovations, including gene therapies, immunotherapies, viral vaccines, oncolytic viruses, and more. ABL's CDMO services include bulk drug substance production, fill/finish of drug products, process development, assay development and release testing.